Original InvestigationMedical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Mancini has received honoraria from Regeneron, Merck Canada, Amgen, Sanofi, Boehringer Ingelheim, and AstraZeneca; and has served on the advisory board for Amgen and Sanofi. Dr. Brooks has received a research grant from Gilead Sciences. Dr. Chaitman has served on the speakers bureau for Gilead Sciences; has served on the advisory boards of Merck, Sanofi, Novo Nordisk, and Lilly; has served on clinical events committees for Merck, Novo Nordisk, and Lilly; and has served on the Data Safety and Monitoring Board of Sanofi. Dr. Boden has received research grants from Abbvie and Amgen; has served on the speakers bureau for Janssen, Merck, Sanofi, and Gilead Sciences; and has served on the advisory boards of Arisaph, CardioDx, Merck, and Sanofi. Ms. Siami has received a research grant from Cordis. Dr. Bittner has received research grants from Bayer Healthcare and Janssen; has received honoraria from Sanofi, Amgen, and AstraZeneca; has served on the advisory board for Lilly and Amgen; and has received a research grant from Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Deepak Bhatt, MD, MPH, served as Guest Editor for this paper.